Sustainability at Biocon

Biocon | Entering adjacencies in communicable disease: infectious disease antibodies and vaccines Key Commercial Products (COVID-19) Biocon Biologics Itolizumab for Injection (r-DNA origin) ALZUMAB-L areaphe.me tolizumab for Injection Orig ALBUMAB-L * Biocon Biologics For India Only Remdesivir for Injection Lyophilized RemWin रेमविन For templa Incote Novel up FORE 100mg CytoSorb REGAIN CONTROL ents inc 50,000+ lives impacted Recent Collaborations g مع a a SII SERUM INSTITUTE OF INDIA Continued portfolio expansion 18

View entire presentation